Skip to main content
Clinical Trials/NCT03996135
NCT03996135
Unknown
Not Applicable

Study of the Effectiveness of a Venous Illumination System for Peripheral Venous Pathways in Cirrhotic Patients

University Hospital, Caen1 site in 1 country280 target enrollmentJune 15, 2020
ConditionsLiver Cirrhosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Cirrhosis
Sponsor
University Hospital, Caen
Enrollment
280
Locations
1
Primary Endpoint
First Attempt Success Rate of Cannulation
Last Updated
3 years ago

Overview

Brief Summary

The objective of this study is to evaluate the effectiveness of AccuVein AV400 to facilitate placement of peripheral intravenous catheters in cirrhotic adults by comparing the success rate of the first attempt to install a peripheral venous catheter with or without AccuVein AV400®.

Registry
clinicaltrials.gov
Start Date
June 15, 2020
End Date
June 30, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient older than 18 years old
  • Patient presenting a liver cirrhosis
  • Patient requiring the placement of a venous peripheral catheter
  • Patient informed and giving free and informed consent
  • Patient affiliated to a French social security scheme

Exclusion Criteria

  • Patient under 18 years old
  • Patient unable to give consent
  • Patient under guardianship or curatorship

Outcomes

Primary Outcomes

First Attempt Success Rate of Cannulation

Time Frame: baseline

Firt attempt success of positional for each peripheral venous catheter and expressed as a percentage in cirrhotic patients during hospitalization.

Secondary Outcomes

  • change of the score A-DIVA(baseline and end of hospitalization (up to a month))
  • Cost(baseline)
  • Pain's score(baseline)
  • Utilisation of a central venous catheter(baseline)
  • Numbers of attempts(baseline)
  • Life expectancy of the catheter(baseline)

Study Sites (1)

Loading locations...

Similar Trials